219TiP - Window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO)
| Autor: | Toms, C., Chopra, N., Houlton, L., Jarman, K., Kilburn, L., Bliss, J., Turner, N. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi66-vi66 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|